JP2007533735A5 - - Google Patents

Download PDF

Info

Publication number
JP2007533735A5
JP2007533735A5 JP2007509422A JP2007509422A JP2007533735A5 JP 2007533735 A5 JP2007533735 A5 JP 2007533735A5 JP 2007509422 A JP2007509422 A JP 2007509422A JP 2007509422 A JP2007509422 A JP 2007509422A JP 2007533735 A5 JP2007533735 A5 JP 2007533735A5
Authority
JP
Japan
Prior art keywords
phenylimidazolidine
enoyl
methylsulfonyl
piperidin
piperidinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007509422A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007533735A (ja
Filing date
Publication date
Priority claimed from SE0401057A external-priority patent/SE0401057D0/xx
Priority claimed from SE0500057A external-priority patent/SE0500057D0/sv
Application filed filed Critical
Priority claimed from PCT/SE2005/000574 external-priority patent/WO2005101989A2/en
Publication of JP2007533735A publication Critical patent/JP2007533735A/ja
Publication of JP2007533735A5 publication Critical patent/JP2007533735A5/ja
Pending legal-status Critical Current

Links

JP2007509422A 2004-04-23 2005-04-20 ケモカイン受容体ccr5のモジュレーターとしてのピペリジン誘導体 Pending JP2007533735A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0401057A SE0401057D0 (sv) 2004-04-23 2004-04-23 Chemical Compounds
SE0500057A SE0500057D0 (sv) 2005-01-10 2005-01-10 Chemical compounds
PCT/SE2005/000574 WO2005101989A2 (en) 2004-04-23 2005-04-20 Piperidine derivatives as modulators of chemokine receptor ccr5

Publications (2)

Publication Number Publication Date
JP2007533735A JP2007533735A (ja) 2007-11-22
JP2007533735A5 true JP2007533735A5 (https=) 2008-06-05

Family

ID=35197429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007509422A Pending JP2007533735A (ja) 2004-04-23 2005-04-20 ケモカイン受容体ccr5のモジュレーターとしてのピペリジン誘導体

Country Status (16)

Country Link
US (2) US7615555B2 (https=)
EP (1) EP1742934A2 (https=)
JP (1) JP2007533735A (https=)
KR (1) KR20070007345A (https=)
AR (1) AR048834A1 (https=)
AU (1) AU2005235169B2 (https=)
BR (1) BRPI0510126A (https=)
CA (1) CA2562417A1 (https=)
IL (1) IL178650A0 (https=)
MX (1) MXPA06012045A (https=)
NO (1) NO20065319L (https=)
RU (1) RU2368608C2 (https=)
SA (1) SA05260099B1 (https=)
TW (1) TW200610761A (https=)
UY (1) UY28870A1 (https=)
WO (1) WO2005101989A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2662835A1 (en) * 2006-09-18 2008-03-27 Remy Lemoine Octahydropyrrolo [3, 4-c] pyrrole derivatives and their use as antiviral agents
TW200831483A (en) * 2006-12-11 2008-08-01 Astrazeneca Ab Chemical compound
TW200831093A (en) * 2006-12-11 2008-08-01 Astrazeneca Ab Chemical compound
EP2112880A4 (en) * 2006-12-14 2011-12-21 Merck Sharp & Dohme ACYLBIPIPERIDINYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND TREATMENT METHOD
WO2008101728A1 (de) * 2007-02-23 2008-08-28 K.H.S. Pharma Holding Gmbh Verfahren zur herstellung von azoniaspironortropinestern und von nortropan-3-on verbindungen
US7977358B2 (en) 2007-07-26 2011-07-12 Hoffmann-La Roche Inc. Pyrazol derivatives
SI2336125T1 (sl) 2008-04-11 2013-04-30 Janssen Pharmaceutica N.V. Tiazolopiridin-2-iloksi-fenil in tiazolopirazin-2-iloksi-fenil amini kot modulatorji levkotrien a4 hidrolaze
US8217060B2 (en) 2009-05-15 2012-07-10 Janssen Pharmaceutica, Nv Benzimidazole derivatives useful as TRP M8 receptor modulators
WO2011011652A1 (en) 2009-07-24 2011-01-27 Glaxosmithkline Llc Therapeutic compounds
CN102241664B (zh) * 2010-05-13 2014-11-12 上海医药工业研究院 芳烷二胺类衍生物及其作为抗抑郁症药物的应用
AU2011256455A1 (en) 2010-05-17 2013-01-10 Array Biopharma Inc. Piperidinyl-substituted lactams as GPR119 modulators
WO2013074641A1 (en) * 2011-11-16 2013-05-23 Array Biopharma Inc. Piperidinyl- substituted cyclic ureas as gpr119 modulators
JP6303250B2 (ja) 2012-12-21 2018-04-04 石原産業株式会社 有害生物防除剤
US9090618B2 (en) 2012-12-27 2015-07-28 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
US10556899B2 (en) * 2018-02-09 2020-02-11 Sci Pharmtech, Inc. Method for preparing Maraviroc
WO2025064788A2 (en) * 2023-09-20 2025-03-27 Cidara Therapeutics, Inc. Ccr5 conjugates and uses thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9100513A (es) 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
WO1999004794A1 (en) 1997-07-25 1999-02-04 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
AR013669A1 (es) * 1997-10-07 2001-01-10 Smithkline Beecham Corp Compuestos y metodos
IL135488A0 (en) * 1997-11-18 2001-05-20 Teijin Ltd Cyclic amine derivatives
WO1999038514A1 (en) 1998-02-02 1999-08-05 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
US6288083B1 (en) * 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
PE20001420A1 (es) * 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
EP1013276A1 (en) 1998-12-23 2000-06-28 Pfizer Inc. Aminoazacycloalkanes as CCR5 modulators
US7217714B1 (en) * 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
SE9902987D0 (sv) * 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CO5300399A1 (es) * 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
GB0005642D0 (en) * 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds
GB0011838D0 (en) * 2000-05-17 2000-07-05 Astrazeneca Ab Chemical compounds
RS50904B (sr) * 2000-05-26 2010-08-31 Pfizer Inc. Derivati tropana i njihova primena
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
US6855724B2 (en) * 2002-04-08 2005-02-15 Agouron Pharmaceuticals, Inc. Tropane derivatives useful in therapy
EP1352672A3 (en) * 2002-04-08 2004-01-07 Acrostak Corp. PTCA and/or PTA balloon
BR0317230A (pt) * 2002-12-13 2005-10-25 Smithkline Beecham Corp Composto, composição, métodos de antagonizar uma atividade do receptor de quimiocina ccr-5, e de tratar uma infecção viral em um paciente, e, uso de um composto
SE0203828D0 (sv) * 2002-12-20 2002-12-20 Astrazeneca Ab Chemical compounds
SE0203820D0 (sv) 2002-12-20 2002-12-20 Astrazeneca Ab chemical compounds
AR042628A1 (es) * 2002-12-20 2005-06-29 Astrazeneca Ab Derivados de piperidina como moduladores del receptor ccr5
SE0401657D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
SE0401656D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
TW200831093A (en) * 2006-12-11 2008-08-01 Astrazeneca Ab Chemical compound
TW200831483A (en) * 2006-12-11 2008-08-01 Astrazeneca Ab Chemical compound

Similar Documents

Publication Publication Date Title
JP2007533735A5 (https=)
JP2008500385A5 (https=)
RU2437882C2 (ru) Производные имидазолидинона
NZ594765A (en) Anthelmintic agents and their use
HRP20110640T1 (hr) Derivati cikličkih amida i njihova proizvodnja te njihova uporaba kao antitromboznih sredstava
PE20080362A1 (es) Derivados de ciclohexilpirazol-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1
NO20061528L (no) Polymrofe former av 3-(4-amino-1-okso-1,3dihydro-isoindol-2-yl)-piperidin-2,6-dion
PE20050087A1 (es) Derivados de 2-oxodihidropiridina n-sustituidos
JP2003267957A5 (https=)
WO2009013211A3 (en) New pyrazol derivatives
PE20050077A1 (es) Derivados de 4-pirrolidino-fenil-bencil-eter
CA2569611A1 (en) Indole derivatives as histamine receptor antagonists
PE20071177A1 (es) Derivados de 3,5-piridina como inhibidores de renina
NO20075022L (no) (7-(2-(4-(3-trifluormetylfenyl)-1,2,3,6-tetrahydropyrid-1-yl)etyl) isokinolinbesylatsalt, fremstilling og terapeutiske anvendelser derav
DE602005012634D1 (en) Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten
HRP20080446T3 (en) Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine
HUP0500241A2 (hu) Polimorf 4-{2-[4-[1-(2-etoxietil)-1H-benzimidazol-2-il]-1-piperidinil]etil}-alfa,alfa-dimetil-benzenoecetsav, eljárás előállításukra, az ezt tartalmazó gyógyszerkészítmények és alkalmazása
MA28329A1 (fr) Formes cristallines de {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]pyridin -3-yl}-(2-chlorophenyl)-methanone.
TWI315667B (en) Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl )piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono -hydrochloride
WO2007087135A3 (en) PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
JP2007505114A5 (https=)
EP4153583C0 (en) 1-((1H-PYRAZOL-4-YL)METHYL)-3-(PHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES AND SIMILAR COMPOUNDS AS GPR139 ANTAGONISTS FOR THE TREATMENT OF DEPRESSION
CA2569861A1 (en) Pyrrolidine derivatives as ccr5 antagonists
PE20061062A1 (es) Derivados de indazol como inhibidores de los transportadores de norepinefrina y serotonina
IL164018A0 (en) Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa